Emerging Research | BeTheCure

Emerging Data & Research

Disclaimer: Is not medical advice but this is evidence based practice and purely informational. Please talk to your healthcare provider. Please make your own health choices.

CDC Recommends Updated COVID-19 Vaccine for Fall/Winter Virus Season

Released Sept. 12 2023

Centers for Disease Control and Prevention

https://www.cdc.gov/media/releases/2023/p0912-COVID-19-Vaccine.html

Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae

Author: Zoe Swank, Et al.

Published: Feb. 1 2023

Clinical Infectious Diseases

This paper provides evidence that there is an association between how much spike protein from a SARSCoV2 infection is concentrated in blood plasma related to the manifestation of post-acute sequelae of coronavirus disease 2019 (PASC), or "long-Covid".

Main points:

We detect severe acute respiratory syndrome coronavirus 2 spike predominantly in PASC patients up to 12 months after diagnosis.

The majority of PASC patients were female (n = 30), reflecting the increased frequency with which women are affected by persistent symptoms following SARS-CoV-2 infection [4].

Of the 3 antigens, we detected spike most often in 60% of the PASC patients, whereas we did not detect spike in the COVID-19 patients. S1 was detected to a lesser degree in about one-fifth of the PASC patients and N was detected in a single patient at multiple time points.

Swank, Z., Senussi, Y., Manickas-Hill, Z., Yu, X. G., Li, J. Z., Alter, G., & Walt, D. R. (2023). Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 76(3), e487–e490. https://doi.org/10.1093/cid/ciac722

Post-acute COVID-19 syndrome

Nalbandian et al.

April 27 2021

Nature Medicine

A comprehensive review of the current literature on post-acute COVID-19, its pathophysiology and its organ-specific sequelae.

Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., Ahluwalia, N., Bikdeli, B., Dietz, D., Der-Nigoghossian, C., Liyanage-Don, N., Rosner, G. F., Bernstein, E. J., Mohan, S., Beckley, A. A., Seres, D. S., … Wan, E. Y. (2021). Post-acute COVID-19 syndrome. Nature medicine, 27(4), 601–615. https://doi.org/10.1038/s41591-021-01283-z

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

Bruce K. Patterson et al,

Dec. 2021

Frontiers in Immunology

Here we report the discovery of persistent SARS-CoV-2 protein in CD14lo, CD16+ monocytes out to 15 months in some individuals and discuss the implications for the pathogenesis of PASC and severe cases of COVID-19.

English: The SPIKE protein does not stay in the ARM and can circulate in your blood for up to 15 months, some people less. That does not mention what organs, tissues, your cardiovascular system, your brain, your immune system, any of those places where these spike proteins may stick to while traveling through your blood stream.

GOOD NEWS: These concentrations vary from person to person depending on average uptake of mRNA, handling of the vaccines, batch numbers, and possibly more. Dr. Peter McCullough and other doctors have asked the question: Is the rate that adverse reactions occur from vaccination for COVID19 is due to "hot-batches"? There may be more to this as we highlight the link between disease caused by spike and adverse reactions caused by vaccine.

My hypothesis is that there is a positive association between concentration of spike protein in the body and an increased rate of a mosaic of diseases being studied today.

Patterson, B. K., Francisco, E. B., Yogendra, R., Long, E., Pise, A., Rodrigues, H., Hall, E., Herrera, M., Parikh, P., Guevara-Coto, J., Triche, T. J., Scott, P., Hekmati, S., Maglinte, D., Chang, X., Mora-Rodríguez, R. A., & Mora, J. (2022). Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Frontiers in immunology, 12, 746021. https://doi.org/10.3389/fimmu.2021.746021

Take a moment. Think about what you are learning.

There is a toxicity to any medicine, even vaccines.

The benefits have to out weight the harms. Correct?

Well think again. Continue.

Data entry in progress . . .

Bio-distribution Study Allegedly from Pfizer

Pfizer

A bio-distribution study from Pfizer to Japanese government:

Shows the lipid-nanoparticle, which holds the mRNA, is distributed to many of the sensitive organs.
Bone Marrow, liver, brain, heart, OVARIES, TESTES.

Start on page 16:

https://www.docdroid.net/xq0Z8B0/pfizer-report-japanese-government-pdf#page=16